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Hypoxia-inducible factor-1 alpha (HIF-1 alpha)
Apoptosis
Cell viability
Lactate dehydrogenase (LDH)It has been demonstrated that hypoxia-inducible factor-1 alpha (HIF-1 alpha) mediates ischemic tolerance
induced by hypoxia/ischemia or pharmacological preconditioning. In addition, preconditioning stimuli can
be cross-tolerant, safeguarding against other types of injury. We therefore hypothesized HIF-1 alpha might
also be associated with ischemic tolerance induced by hyperthermic preconditioning. In the present study,
we demonstrated for the ﬁrst time that 6 h of hyperthermia (38 °C or 40 °C) could induce a characteristic
“reactive” morphology and a signiﬁcant increase in the expression of bystin in astrocytes. We also showed
that pre-treatment with 6 h of hyperthermia resulted in a signiﬁcant increase in cell viability and a
remarkable decrease in lactate dehydrogenase (LDH) release and apoptosis development in the astrocytes
that were exposed to 24 h of ischemia and a subsequent 24 h of reperfusion. Analysis of mechanisms showed
that hyperthermia could lead to a signiﬁcant increase in HIF-1 alpha expression and also the HIF-1 binding
activity in the ischemia/reperfusion astrocytes. The data provide evidence to our hypothesis that the up-
regulation of HIF-1 alpha is associated with the protective effects of hyperthermic preconditioning on
astrocytes against ischemia/reperfusion injury.ces, Faculty of Medicine, The
g.
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Preconditioning was ﬁrst described in a dog model of myocardial
injury in which sublethal ischemia enabled cells to better tolerate
subsequent usually lethal ischemia [1]. It is now recognized that this
phenomenon can be induced not only by ischemia but also by a
number of other stimuli including hypothermia and hyperthermia in
the central nervous system [2]. During the past years, the phenom-
enon has received much attention because of its potential therapeutic
importance [2,3].
A number of studies have demonstrated that preconditioning
induced by hyperthermia (hyperthermic preconditioning) can pro-
duce a signiﬁcant protecting effect in experimental animals. It has
been reported that hyperthermic preconditioning protects against
subsequent forebrain ischemic cell damage [4], spinal cord ischemic
injury [5,6] and the lethal effects of endotoxin [7] in rats or mice. The
studies also showed that hyperthermia prevents disruption of blood–
brain barrier and ameliorates hypoxic-ischemic neuronal damage in
newborn rat [8], and reduces the volume of middle cerebral artery
occlusion (MCAO)-induced cerebral infarction [9] and the kainic acid-induced neuronal cell loss [10] in rats. In addition, it has been
demonstrated that hyperthermia provides a continuous long-term
and constant inhibitory effect on postischemic injury of the liver [11]
and protects pig islet grafts from early inﬂammation in mice [12].
The accumulated data suggested that these beneﬁcial effects might
be associated with an increased expression of heat shock proteins
(HSPs) [6,7,13,14] and heme oxygenase (HO-1) [11,15], the central
adenosine receptors [9] and the upregulation of the polysialylation of
neural cell adhesion molecule [10] in the rat brain. However, study on
the mechanisms of the protective effects induced by hyperthermic
preconditioning in the brain is still in its infancy. In addition to the
above pathways, it is clear that cells have other mechanisms that have
not yet been elucidated [16].
Preconditioning stimuli can be cross-tolerant, safeguarding
against other types of injury [2]. Thus, there may be some
overlapping mechanisms in preconditioning and unraveling these
pathways may uncover an arsenal of neuroprotective therapeutic
targets [2]. Accumulated evidence has demonstrated that hypoxia-
inducible factor-1 alpha (HIF-1 alpha) mediates ischemic tolerance
induced by hypoxia/ischemia preconditioning [17,18]. Our recent
studies showed that pharmacological preconditioning (ginkgolides)
can mimic the effects of hypoxic preconditioning to protect primary
cultured neurons, astrocytes, PC12 and C6 cells against ischemic
injury by up-regulation of HIF-1 alpha [17–20]. In addition, HSPs and
HO-1 both are the target genes of HIF-1 alpha [21–23] and their
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Based on these facts, we therefore hypothesized that the up-
regulation of HIF-1 alpha might also be associated with the
protective effects of hyperthermic preconditioning on brain cells.
To test the hypothesis, we investigated effects of hyperthermia on
the expression of HIF-1 alpha in the ischemia/reperfusion-astrocytes
in the present study.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all chemicals were obtained from Sigma
Chemical Company, St. Louis, MO, USA. Anti-HIF-1 alpha monoclonal
antibody was purchased from Novus Biologicals, Littleton, CO, USA
and the secondary antibodies (HRP-conjugated goat anti-rabbit IgG
and goat anti-mouse IgG) were from Pierce, Rockford, IL, USA. Heat-
inactivated fetal bovine serum and Dulbecco's modiﬁed Eagle's
medium (DMEM) were obtained from Gibco BRL, Gaithersburg, MD,
USA and acrylamide and bisacrylamide were purchased from Bio-Rad
Laboratories, Richmond, CA, USA. The solutions, buffers and media
used in cell culture were desterilized by passing through 0.22-μm
Millipore ﬁlters. ICR mice were supplied by the Animal House of
Nantong University Medical Center. The Health Department of
Nantong Government and Animal Ethics Committee of Nantong
University approved the use of animals for this study. All the animals
were housed in pairs in stainless steel cages at 21±2 °C with relative
humidity of 60–65% and alternating 12-h periods of light (7:00–
19:00) and darkness (19:00–7:00).
2.2. Mouse astrocytes
The mouse cerebrocortical astrocytes were prepared from new-
born ICR mice by a procedure previously described [24,25]. Brieﬂy,
cerebral cortex was cut into small cubes (b1 mm3) and digested with
0.25% trypsin (Sigma, USA) for 30 min at 37 °C. Trypsinization was
terminated by an addition of DMEM containing 10% fetal bovine
serum, followed by the mechanical trituration with a ﬂame-polished
Pasteur glass pipette. Cell suspensions were sieved through a 40-mm
cell strainer and the ﬁltrate was allowed preadherence for 30 min to
remove any contamination from ﬁbroblast before being seeded at a
density of approximately one cerebrum per 50 cm2 ﬂask (Corning,
USA) or six-well plates (NUNC, Denmark). The plated cells were
incubated in a 5% CO2 incubator (NAPCO 5400) at 37 °C. After the
cultures reached conﬂuence (12–14 days), they were sub-cultured 3
times every 4 days and allowed pre-adherence for 30 min before
being seeded in each subculture. The purity of the astrocyte cultures
was assessed by staining for the astrocyte marker glial ﬁbrillary
acidic protein (GFAP) (Chemicon International Ltd., UK), which was
approximately 99%.
2.3. Experimental design
Ischemic cortical astrocytes were prepared as previously described
[20,26]. Brieﬂy, astrocytes in Hank's solution without glucose and
serum (oxygen–glucose deprivation, OGD)were exposed to 1% O2 in a
dedicated incubator (NAPCO 7101FC-1) at 37 °C for 24 h. Reperfusion
was conducted by the treatment of the cells in normal cultural
medium (DMEM containing 10% fetal bovine serum) with nomoxia
(21% O2) in a humidiﬁed incubator at 37 °C for 24 h.
To observe the effects of hyperthermic preconditioning on the
viability of ischemic astrocytes, the cells were incubated at 37 °C
(normothermia), 38 °C or 40 °C (hyperthermia) for 6 h based on our
preliminary experiments, and then exposed to ischemia and reperfu-
sion, respectively, for 24 h. After the above treatments, cell viability
was determined.To understand the mechanism involved in the protective effect of
hyperthermic preconditioning on astrocytes from ischemia/reperfu-
sion injury, we investigated HIF-1alpha expression in astrocytes pre-
treated with hyperthermia. The cells were exposed to normothermia
(37 °C) or hyperthermia (38 or 40 °C) for 6 h and then lysed and the
expression of HIF-1alpha was measured using Western blot analysis.
The binding activity of HIF-1alpha was also determined by a
Electrophoretic Mobility Shift Assays (EMSA) method.
2.4. Morphological observation
Effects of hyperthermic preconditioning on morphological
changes of astrocytes were observed under phase contrast microsco-
py as described previously [26].
2.5. Cell viability
The cell viabilities of astrocytes that received different treatments
were measured using an MTT (3-(4,5-dimethylthazol-2-yl)-2,5-
diphenyltetrazolinum bromide) assay as described by He et al. [13].
Brieﬂy, a total of 25 μL MTT (1 g/L in PBS) was added to each well
before the conduction of incubation at 37 °C for 4 h. The assay was
stopped by the addition of a 100 μL lysis buffer (20% SDS in 50% N'N-
dimethylformamide, pH 4.7). Optical density (OD) was measured at
the 570 nm wavelength by the use of an ELX-800 microplate assay
reader (Bio-tek, USA) and the results were expressed as a percentage
of absorbance measured in the control cells.
2.6. Lactate dehydrogenase
The quantity of lactate dehydrogenase (LDH) release in the
medium was determined by the decrease in absorbance at 340 nm
for NADH disappearance within 3 min [27]. Brieﬂy, the cells were
treated as described in Experimental design, 500 μl of supernatant
was then collected from each well and mixed with 1.3 ml of NADH
(0.217 mmol/l) and 1.3 ml of sodium pyruvate (1.77 mmol/l) in the
modiWed Krebs–Henseleit buffer (118 mmol/l NaCl, 4.8 mmol/l KCl,
1 mmol/l KH2PO4, 24 mmol/l NaHCO3, 3 mmol/l CaCl2, 0.8 mmol/l
MgPO4, pH 7.4) at 37 °C for 30 s. The activity was spectrophotomet-
rically measured by the use of an ELX-800 microplate assay reader
(Elx800, Bio-tek, USA) at OD 340 nm.
2.7. Hoechst 33342 staining
Hoechst 33342 staining was used to detect the morphological
features of apoptotic cell death [20]. Astrocytes that received different
treatments were stained with Hoechst 33342 (1 mg/ml) for 1 h. The
cells were then examined under a ﬂuorescent microscope (Leica,
Wetzlar, Germany) equipped with a SPOT cool CCD camera (Canon,
Japan) with a 350-nm excitation laser. Undamaged cell nuclei were
large and diffusely stained whereas apoptotic nuclei showed chromatin
that was condensed and fragmented.
2.8. Western blot analysis
Western blot analysis was performed as described previously
[17,18]. The cells that received different treatments were washed
twice with ice-cold phosphate-buffered saline (PBS). The proteins
were extracted with 150 ml cold lysis buffer (50 mmol/l Tris–HCl
with pH 6.8, 1 mmol/l EDTA, 1% SDS, 1% Nonide P-40, 1 mmol/l
Na3VO4, 1 mmol/l NaF, 5% bmercaptoethanol, 0.4 mmol/l phenyl-
methylsulfonyl ﬂuoride (PMSF), 2 mg/l Aprotinin, 2 mg/l Leupeptin,
and 2 mg/l Pepstain). Lysates were kept in ice for 30 min and
centrifuged at 12,000 rpm at 4 °C for 15 min. The supernatant was
collected and the protein content was determined using the Bradford
assay kit (Bio-Rad, Hercules, CA, USA). The proteins were separated by
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diﬂuoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA) previous-
ly blocked with 5% non-fat milk in TBS-T (20 mM Tris-buffered saline
with pH 7.5 and 0.1% Tween-20), and incubated overnight at 4 °C with
the indicated primary monoclonal mouse anti-HIF-1 alpha (1:500
dilution, Novus Biologicals, Littleton, CO, US), bystin (1:10000
dilution, a gift from Jiawei Zhou, Shanghai Institutes for Biological
Sciences, China) or primary monoclonal mouse anti-GFAP (1:20000
dilution, Chemicon International Ltd., UK) and then incubated with a
horseradish peroxidase (HRP)-conjugated secondary antibodies
(1:1000 dilution, Pierce Chemical Company, USA) for 2 h at room
temperature. Immunolabeling was detected by using the Super Signal
West Femto Maximum Sensitivity Substrate (Pierce Biotechnology,
Inc., Rockford, IL, USA). The intensity of each band was quantiﬁed by
using Scion Image software (Scion Corp., Frederick, MD, USA). To
ensure even loading of the samples, the same membrane was probed
with the anti-mouse beta-actin monoclonal antibody (Sigma-Aldrich,
MO) at 1:10,000 dilution.
2.9. Electrophoretic mobility shift assays
Nuclear extracts were prepared using the NE-PER kit (#78833,
Pierce Biotechnology, Rockford, IL,USA) according to the instructions
of the manufacturer. Using the lightshift chemiluminescent EMSA kit
(#20148, Pierce Biotechnology, Rockford, IL ,USA), the binding
reaction mixtures were mixed in a volume of 15 μl with a ﬁnal
concentration of 5 μg nuclear proteins, 0.2 μg poly (dI·dc), 2 μl
10×binding buffer, the bio-labeled oligonucleotide probe (20 ng in
2 μl) and incubated for 30 min at room temperature [18]. For speciﬁc
competition EMSA, a 200-fold excess of the cold (unlabled)
oligonucleotides (4 μg in 2 μl) was added simultaneously during the
incubative period. A 200-fold excess of the unlabeled probes (4 μg in
2 μl) harboring mutated HIF-binding site (HRE) was used as the
nonspeciﬁc competition EMSA. The bio-labeled oligonucleotide probe
harboring mutated HRE (20 ng in 2 μl) was also used to test the
speciﬁcity of the binding reaction. To separate from unbound DNA, the
DNA–protein complexes were resolved on 6% native polyacrylamide
gels [18].Fig. 1. Effects of hyperthermia on the morphology and the expressions of GFAP and byst
hyperthermia (38 °C or 40 °C) for 6 h. The morphological changes were then observed under
blot analysis as described in Materials and methods. (A) The control (normothermia, 37 °C)
(D and F) A representative experiment of Western blot analysis of GFAP (D) and bystin (
astrocytes. The values were the Mean±SEM (n=4). *pb0.05 vs. normothermia group.2.10. Statistical analysis
Statistical analyses were performed using SPSS 10.0. Data are
presented as Mean±S.E.M. The difference between means was
determined by one-way ANOVA followed by a Student–Newman–
Keuls test for multiple comparisons. A probability value of pb0.05 was
taken to be statistically signiﬁcant.
3. Results
3.1. Effects of hyperthermia on the morphology and the expressions of
GFAP and bystin in astrocytes
We ﬁrst observed the hyperthermic preconditioning-induced
morphological changes of astrocytes using phase contrast microscope.
Treatment of the cells with hyperthermia (Fig. 1B: 38 °C or Fig. 1C:
40 °C) for 6 h induced a characteristic “reactive” morphology, i.e.
hypertrophic processes and stellate-shaped cell bodies. There were no
signiﬁcant changes in the morphology of astrocytes pre-exposed to
37 °C (normothermia) for 6 h (Fig. 1A).
Our recent study demonstrated that bystin is a much more
sensitive marker in activated astrocytes than GFAP [20]. Therefore, we
then examined effects of hyperthermia on the expression of bystin
and also GFAP in astrocytes. Western blot analysis showed that
treatment of the cells with 40 °C (hyperthermia) for 6 h induced a
signiﬁcant increase in the expression of GFAP (Fig. 1D and E; pb0.05,
vs. the control), but no signiﬁcant difference in the expression of GFAP
was found between the cells incubated at 38 °C (hyperthermic) and
37 °C (the control). However, in the case of the expression of bystin,
the signiﬁcant differenceswere found between the cells incubated not
only at 40 °C and 37 °C (the control) but also 38 °C and 37 °C (the
control) (Fig. 1F and G, pb0.05, vs. the control).
3.2. Hyperthermic preconditioning protected astrocytes from the injury
induced by ischemia and reperfusion
To ﬁnd out whether there are any protective effects of hyperther-
mia preconditioning on astrocytes against ischemia/reperfusionin of astrocytes. Primary astrocytes were exposed to either normothermia (37 °C) or
a light microscope and the expressions of GFAP and bystin was determined byWestern
. (B) hyperthermia (38 °C) for 6 h; C. hyperthermia (40 °C) for 6 h (scale bar=10 μm).
F) respectively. E and G. Quantiﬁcations of expression of GFAP (E) and bystin (G) in
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40 °C (hyperthermia) for 6 h before exposed to ischemia and
reperfusion, respectively, for 24 h, after which cell viability, LDH
release and morphological changes were observed. It was found that
ischemia and reperfusion (I/R) induced a signiﬁcant decrease in the
viability of astrocytes (Fig. 2A, pb0.01 vs. the control) and increase in
LDH release (Fig. 2B, pb0.01 vs. the control). The pre-treatement of
the cells with 38 °C or 40 °C (hyperthermia) for 6 h led to a signiﬁcant
increase in the viability (Fig. 2A,) and decrease in LDH release (Fig. 2B)
in the astrocytes treated with I/R. The viability was signiﬁcantly
higher and the LDH release signiﬁcantly lower in the cells of “38D+IR”
and “40D+IR” groups (38 °C or 40 °C for 6 hﬁrst and then I/R for 24 h)
than in the cells of I/R group (All pb0.01 vs. I/R). In agreement with
the above results, treatments of the astrocytes with ischemia and
reperfusion for 24 h induced a signiﬁcant change in cell morphology.Fig. 2. Effects of hyperthermic preconditioning on cell-viability, LDH release and the
morphology of astrocytes. The astrocytes were pre-incubated at 37 °C (normothermia),
38 °C or 40 °C (hyperthermia) for 6 h before exposed to 24 h of ischemia and a
subsequent 24 h of reperfusion. The relevant observation andmeasurements were then
conducted as described in Materials and methods. (A) Cell-viability; (B) LDH release;
and (C) morphological changes: I. the control [pre-treated with 37 °C for 6 h,]; II. I/R
[24 h of ischemia and 24 h of reperfusion]; III. 38D+I/R [pre-treated with 38 °C for
6 h]; and IV. 40D+I/R [pre-treated with 40 °C for 6 h] (scale bar=10 μm). The values
were the Mean±SEM. **pb0.01, vs. the control; ##pb0.01, vs. I/R group.Cell bodies began to shrink and processes decurtated or even
disappeared. Relics of the dead cells could be found under a light
microscope (Fig. 2C-II). The astrocytes treated with hyperthermia
preconditioning (38 °C, Fig. 2C-III, or 40 °C, Fig. 2C-IV) for 6 h before
exposed to ischemia (24 h) and reperfusion (24 h) acquired reactive
morphology. The data imply that hyperthermic preconditioning has
protective effect on astrocytes against ischemia/reperfusion-induced
injury.
3.3. Hyperthermic preconditioning enhances anti-apoptotic abilities in
I/R astrocytes
To understand the mechanisms involved in the protective effect of
hyperthermic preconditioning on astrocytes from I/R injury, we ﬁrst
investigated whether hyperthermic preconditioning has any anti-
apoptotic abilities in I/R astrocytes. Fig. 3 presents the results of
Hoechst 33342 staining analysis. In Fig. 3A-I (the control), apoptotic
nuclei were absent. However, in the I/R astrocytes (Fig. 3A II), nearly
all nuclei were condensed and densely stained with a much brighter
blue ﬂuorescence as compared with the controls in Fig. 3A-I. The
apoptosis induced by ischemia and reperfusion was effectively
reversed by pre-treatment with hyperthermia (38 °C, Fig. 3A-III or
40 °C, Fig. 3A-IV) for 6 h. The nuclei of astrocytes in these two groupsFig. 3. Effects of hyperthermic preconditioning on apoptosis induced by ischemia and
reperfusion in astrocytes. The astrocytes were pre-incubated at 37 °C (normothermia),
38 °C or 40 °C (hyperthermia) for 6 h before exposed to 24 h of ischemia and a
subsequent 24 h of reperfusion. Hoechst 33342 staining was then conducted as
described in Materials and methods. (A) Fluorescent photographs of Hoechst 33342
staining analysis: I. the control [pre-treated with 37 °C for 6 h,]; II. I/R [24 h of ischemia
and 24 h of reperfusion]; III. 38D+I/R [pre-treatedwith 38 °C for 6 h]; and IV. 40D+I/R
[pre-treatedwith 40 °C for 6 h] (scale bar=50 μm), (B) apoptotic nucleus/total nucleus
(%). The values were the Mean±SEM (Six view sights of each group were counted and
each group was repeated for three times). **pb0.01, vs. the control; ##pb0.01, vs. I/R
group; @pb0.05, vs. 38D+I/R group.
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found in the cells pre-treated with 40 °C for 6 h (Fig. 3A-IV). The pre-
treatment of astrocytes with 38 °C or 40 °C (hyperthermia) for 6 h
before I/R led to a signiﬁcant decrease in apoptotic nuclei/total nuclei
(%) (Fig. 3B). The apoptotic nuclei/total nuclei (%) was signiﬁcantly
lower in the cells of “38D+IR” and “40D+IR” groups than in the cells
of I/R group (All pb0.01, vs. I/R). These ﬁndings imply that
hyperthermia enhances the anti-apoptotic abilities in I/R astrocytes.
3.4. Effects of hyperthermic preconditioning on the expression of HIF-1
alpha and the binding activity of HIF-1 in nuclear proteins to the HRE of
erythropoietin gene
To better understand the mechanisms involved in the protective
role of hyperthermic preconditioning, we also investigated effects of
hyperthermic preconditioning on the HIF-1 alpha expression using
Western blot analysis and binding activity in nuclear proteins to the
HRE of erythropoietin (EPO) gene by an EMSA method. Western blot
data showed that treatment with 38 °C or 40 °C (hyperthermia) for
6 h could lead to a signiﬁcant increase in the expression of HIF-1
alpha in the astrocytes. The contents of HIF-1 alpha in the cells
treated with 38 °C or 40 °C for 6 h were signiﬁcantly higher than
those in the cells treated with 37 °C for 6 h (Fig. 4A and B, All pb0.01
vs. 37 °C). There are no statistical differences in HIF-1 alpha
expression between the astrocytes treated with 38 °C and 40 °C
hyperthermia (p=0.05457).
The test of EMSA aims to identify transcription factor complexes
binding to the functional HRE within the EPO enhancer element.
Nuclear extracts from astrocytes treated with hyperthermia (38 °C or
40 °C) for 6 h were incubated with bio-labeled probes harboring the
HRE. There are signiﬁcant bands shifted upward in the groups of
hyperthermia (38 °C or 40 °C), the most signiﬁcant being in the
hyperthermia 40 °C group (Fig. 4C, line 4) the control group (37 °C,
line 2) and free group (no protein) (Fig. 4C, the 1st line). These EMSA
results demonstrated that the binding activity of HIF-1 in nuclear
proteins to the HRE of EPO gene increases in astrocytes treated with
hyperthermia.Fig. 4. Effects of hyperthermic preconditioning on expression of HIF-1alpha and binding
activity of HIF-1 in nuclear proteins to the HRE of EPO gene in astrocytes. The astrocytes
were incubated at 37 °C (normothermia), 38 °C or 40 °C (hyperthermia) for 6 h and
thenWestern blot analysis and EMSA test were conducted as described inMaterials and
methods. (A) A representative experiment of Western blot analysis of HIF-1 alpha
(a single band with amolecular weight of ∼120 kDa); (B) quantiﬁcations of HIF-1 alpha
expression; (C) binding activity. The values were the Mean±SEM (n=3, three
independent experiments). **pb0.01 vs. 37 (37 °C, normothermia).4. Discussion
Astrocytes are increasingly recognized for their impact on neuronal
function and viability in health and disease [28]. By inﬂuencing the
glutamate excitotoxicity, oxidative stress and acidosis which are
primarymediators of neuronal death during ischemia and reperfusion
[29–31], astrocytes could effectively protect neuron from ischemia
and reperfusion-induced injury. Astrocytes have the ability to take up
glutamate and reduce excitotoxic glutamate in the extracellular space
of the brain [32], release ascorbate and take up its oxidized form
(dehydroascorbate) to inﬂuence neuronal antioxidant status [29], and
secrete nitric oxide, TNF alpha, matrix metalloproteinase and other
factors to delay neuronal death [29].
A number of studies have demonstrated that preconditioning
induced by hyperthermia could produce a signiﬁcant protecting effect
in experimental rats and mice [4–6,8,10,33]. The protecting effects on
astrocytes induced by hyperthermic preconditioning have also been
reported by some recent studies in experiments in vitro [13,34]. In the
present study, we demonstrated for the ﬁrst time that 6 h of
hyperthermia (38 °C or 40 °C) could induce a characteristic ‘reactive’
morphology (hypertrophic processes and stellate-shaped cell bodies)
and a signiﬁcant increase in the expression of bystin which is a
sensitive marker of the activation of astrocytes. Our ﬁndings also
demonstrated that pre-treatment with 6 h of hyperthermia resulted
in a signiﬁcant increase in the viability and a remarkable decrease
in LDH release and apoptosis development in the astrocytes that
had been exposed to 24 h of ischemia and a subsequent 24 h of
reperfusion. These ﬁndings provided further evidence for the
protecting effects of hyperthermic preconditioning on astrocytes
against ischemia/reperfusion injury.
Although it has been reported that HSP70 [13] and the activation of
MAPK pathways including extracellular signal-regulated protein
kinase (ERK), c-Jun NH(2)-terminal kinase (JNK), and p38 MAPK
[34] might be involved in, the mechanism of the protective effects of
hyperthermic preconditioning on astrocytes is still unclear. Oxygen
availability is crucial for cellular viability. HIF-1 is the major oxygen
homeostasis regulator that plays an essential role in cellular oxygen
homeostasis, functioning as a widely operative transcriptional control
system responding to physiological levels of cellular hypoxia [35–37].
The regulation of the HIF-1 activity depends mostly upon the alpha
subunit and the up-regulation of HIF-1 alpha has been associated with
the cell-protective roles of hypoxic preconditioning and pharmaco-
logical preconditioning [17–29]. Our ﬁndings showed that 6 h of
hyperthermia could lead to a signiﬁcant increase in the expression of
HIF-1 alpha and also the binding activity of HIF-1alpha in the
ischemia/reperfusion astrocytes, providing direct evidence to our
hypothesis.
Thomas et al. [13] demonstrated that upon exposure to elevated
temperature (39 °C), cultured astrocytes from rat diencephalon
express high levels of HSP70, which plays important roles in
maintaining cellular integrity and viability, and are less vulnerable
to a subsequent oxidative stress. It has also been reported that
hyperthermic preconditioning induces strong and long-lasting HO-1/
HSP32, HSP72 and HSP90 expression in rat kidneys [15] and HO-1/
HSP32 and HSP70 expression in the liver [11]. Both HSPs and HO-1 are
the target genes of HIF-1 alpha [21–23]. Therefore, it is highly likely
that the up-regulation of HSPs and HO-1 reported by these
laboratories might be due to the increased expression and binding
activity of HIF-1 alpha. It is also possible that the increased expression
of HSPs and HO-1, induced by up-regulation of HIF-1 alpha, might also
be involved in the protective effects on astrocytes from ischemia/
reperfusion injury found in the present study although we did not
directly measure the expression of HSPs and HO-1.
It has been reported that bystin, a protein potentially involved
in embryo implantation, is markedly up-regulated in the reactive
astrocytes of both 6-hydroxydopamine lesioned nigrostriatum and
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cortical astrocytes treated with pro-inﬂammatory mediators lipo-
polysaccharide and interleukin-1b in vitro [38]. In a recent study, we
found that the response of this protein to ischemia and hypoxia was
much more sensitive than GFAP. This suggested that bystin is a much
more sensitive marker than GFAP in the activation of astrocytes
induced by ischemia and hypoxia [26]. Bystin might be a key factor in
the formation of "reactive" astrocytes induced by not only hypoxia
and ischemia [26] but also hyperthermic preconditioning. Reactive
astrocytes secrete erythropoietin, a paracrine messenger that could
stimulate the Janus kinase-2 (JAK-2) and nuclear factor-kappaB (NF-
κB) signalingpathways to prevent programmedcell deathor apoptosis
after ischemic injury or excitotoxic stress [28]. This mechanism might
also be involved in the increased anti-apoptotic abilities of astrocytes
induced by hyperthermic preconditioning in the present study against
I/R injury.
In summary, the ﬁndings in the present study provided further
evidence that hyperthermic preconditioning (6 h of hyperthermia)
plays a signiﬁcant role in protecting astrocytes against ischemia/
reperfusion injury. Analysis of the mechanisms showed that the
protecting effects of hyperthermic preconditioning might be associ-
ated with the up-regulation of HIF-1 alpha and the increased anti-
apoptotic abilities of astrocytes.
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